Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
28.03
+1.64 (6.23%)
At close: Apr 29, 2026, 4:00 PM EDT
28.03
0.00 (0.00%)
After-hours: Apr 29, 2026, 4:10 PM EDT
Forte Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 76.96 | 22.24 | 37.13 | 41.1 | 42.04 | Upgrade
|
| Short-Term Investments | - | 36.12 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 76.96 | 58.37 | 37.13 | 41.1 | 42.04 | Upgrade
|
| Cash Growth | 31.86% | 57.21% | -9.67% | -2.25% | -28.45% | Upgrade
|
| Other Receivables | 0.82 | 0.13 | - | - | - | Upgrade
|
| Receivables | 0.82 | 0.13 | - | - | - | Upgrade
|
| Prepaid Expenses | 2.39 | 2.65 | 1.04 | 0.34 | 0.39 | Upgrade
|
| Other Current Assets | 0.42 | 0.21 | 0.17 | 0.07 | 0.09 | Upgrade
|
| Total Current Assets | 80.59 | 61.35 | 38.33 | 41.51 | 42.52 | Upgrade
|
| Property, Plant & Equipment | 0.13 | 0.08 | 0.11 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.11 | Upgrade
|
| Other Long-Term Assets | 2.06 | 0.14 | 0.54 | 0.49 | 0.68 | Upgrade
|
| Total Assets | 82.78 | 61.56 | 38.98 | 42 | 43.31 | Upgrade
|
| Accounts Payable | 9.99 | 4.88 | 1.42 | 1.15 | 0.95 | Upgrade
|
| Accrued Expenses | 9.84 | 4.2 | 2.24 | 2.03 | 0.81 | Upgrade
|
| Other Current Liabilities | 0.93 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 20.75 | 9.08 | 3.67 | 3.18 | 1.76 | Upgrade
|
| Other Long-Term Liabilities | 1.04 | - | - | - | - | Upgrade
|
| Total Liabilities | 21.79 | 9.08 | 3.67 | 3.18 | 1.76 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 284.35 | 206.46 | 153.83 | 125.84 | 114.7 | Upgrade
|
| Retained Earnings | -223.37 | -154 | -118.52 | -87.04 | -73.17 | Upgrade
|
| Comprehensive Income & Other | 0 | 0.01 | 0 | - | - | Upgrade
|
| Total Common Equity | 60.99 | 52.48 | 35.31 | 38.82 | 41.55 | Upgrade
|
| Shareholders' Equity | 60.99 | 52.48 | 35.31 | 38.82 | 41.55 | Upgrade
|
| Total Liabilities & Equity | 82.78 | 61.56 | 38.98 | 42 | 43.31 | Upgrade
|
| Net Cash (Debt) | 76.96 | 58.37 | 37.13 | 41.1 | 42.04 | Upgrade
|
| Net Cash Growth | 31.86% | 57.21% | -9.67% | -2.25% | -28.45% | Upgrade
|
| Net Cash Per Share | 5.23 | 20.02 | 29.40 | 59.11 | 75.25 | Upgrade
|
| Filing Date Shares Outstanding | 18.77 | 6.58 | 1.46 | 0.84 | 0.59 | Upgrade
|
| Total Common Shares Outstanding | 17.83 | 6.39 | 1.45 | 0.84 | 0.59 | Upgrade
|
| Working Capital | 59.84 | 52.27 | 34.66 | 38.33 | 40.76 | Upgrade
|
| Book Value Per Share | 3.42 | 8.21 | 24.30 | 46.21 | 70.40 | Upgrade
|
| Tangible Book Value | 60.99 | 52.48 | 35.31 | 38.82 | 41.55 | Upgrade
|
| Tangible Book Value Per Share | 3.42 | 8.21 | 24.30 | 46.21 | 70.40 | Upgrade
|
| Machinery | 0.24 | 0.13 | 0.12 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.